Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Open accessAbstract
Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer's disease (AD) and Parkinson's disease (PD), yet the clinical failures of the recent decades indicate that there are further pathological mechanisms at work. Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impaired neurogenesis and, of course, widespread axonal, synaptic and neuronal degeneration that leads to cognitive and motor impediments. Interestingly, the acylated form of the hormone ghrelin has shown the potential to ameliorate the latter pathologic changes, although some studies indicate a few complications that need to be considered in the long-term administration of the hormone. As such, this review will illustrate the wide-ranging neuroprotective properties of acylated ghrelin and critically evaluate the hormone's therapeutic benefits for the treatment of AD and PD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The beneficial role of ghrelin in the central nervous system has been widely discussed, including enhanced cognition.
“Moreover, the beneficial role of ghrelin in the central nervous system has been widely discussed, including enhanced cognition [48, 59–61].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Haleng, J., Pincemail, J., Defraigne, J., Charlier, C., & Chapelle, J. (2007) · Revue Medicale de Liege · doi:10.1007/springerreference_224261 · Cited by 7,347 · cited 1×
“, 2019), oxidative stress (Cenini et al., 2019), chronic systemic inflammation, pathological immune cell infiltration into the brain (Amor and Woodroofe, 2014; Anderson et al.”
BackgroundAMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · see citing works
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326 · cited 1× · see citing works
“Thus, obesity and T2DMassociated hyperleptinemia (Maffei et al., 1995; Considine et al., 1996; Okumura et al., 2003; Pandey et al., 2015) may contribute to the desensitization of AG in the hypothalamus.”
BackgroundAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689 · cited 1× · see citing works
“Furthermore, in IGF1-positive brain areas, the increased phosphorylation of Akt, enhanced levels of the apoptosis-suppressing protein Bcl-2 as well as the inactivation of the apoptosis-mediator Bad were detected (Datta et al., 1997).”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1× · see citing works
“Given the pivotal role of mitochondrial dysfunction in PD, toxins that are selectively taken up by dopaminergic neurons and impair mitochondrial complex 1, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), kill SN-located, dopaminergic neurons and induce Parkinsonism in humans and rodents (see Figure 2) (La…”
BackgroundAMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,094 · cited 1× · see citing works
“, 2014), which is a master effector that upregulates ATP synthesis, curbs ATP utility, maintains the mitochondrial homeostasis and navigates mitophagy when the cellular energy stores are depleted (Herzig and Shaw, 2018).”
BackgroundLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 1× · see citing works
“, 2007) and deacetylates nuclear PGC1α to initiate mitochondrial biogenesis (Lagouge et al., 2006) as well as the transcription factor forkhead box protein O1 (FoxO1) to amplify the expression of PGC1α (Daitoku et al.”
BackgroundTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · cited 1× · see citing works
“autophagy and, typically in response to stressful cellular conditions and starvation, the activating phosphorylation of the cytoplasmic energy-sensor AMPK results in the AMPK-mediated phosphorylation of TSC1/2 and the inhibition of mTORC1 (Inoki et al., 2003;Manning andCantley, 2003; Demetriades et al., 2016).”
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882 · cited 1× · see citing works
“Thus, impairments in autophagy induce neurodegeneration independent of amyloid accumulation in affected brain areas (Hara et al., 2006; Komatsu et al., 2006).”
BackgroundMaffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725 · cited 1× · see citing works
“Thus, obesity and T2DMassociated hyperleptinemia (Maffei et al., 1995; Considine et al., 1996; Okumura et al., 2003; Pandey et al., 2015) may contribute to the desensitization of AG in the hypothalamus.”
BackgroundLoss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · see citing works
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · see citing works
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · cited 3× · see citing works
“, 2016), vascular abnormalities, reduced blood flow, blood brain barrier (BBB) damage (Kisler et al., 2017; Sweeney et al., 2018), dysfunctional autophagy and mitophagy (Kerr et al.”
BackgroundA preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · cited 1× · see citing works
“Mature ghrelin is stored within secretory granules of X/A-like cells and released into the bloodstream upon fasting to stimulate appetite (Cummings et al., 2001; Yanagi et al., 2018).”
BackgroundDiagnosis and Treatment of Parkinson Disease: A Review
Armstrong, M. J., & Okun, M. S. (2020) · JAMA · doi:10.1001/jama.2019.22360 · Cited by 2,924 · see citing works
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813 · cited 1× · see citing works
“To recharge NAD and FAD and to resume ATP generation, the brain relies on glucose as major energy substrate as well as its metabolization in the tricarboxylic acid cycle (TCA) as main bioenergetic pathway (Penicaud et al., 2002; Arun et al., 2016; Martinez-Reyes and Chandel, 2020).”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · see citing works
How to Interpret LC3 Immunoblotting
Mizushima, N., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4600 · Cited by 2,595 · cited 1× · see citing works
“AG-driven autophagy is dependent on the stimulation of AMPK, leading to increased levels of ATG5, ATG7, ATG12, and Beclin-1, lessened p62 levels (an autophagy marker that is adversely correlated with autophagy), an elevated microtubule-associated protein light chain 3 (LC3)-II/LC3-I ratio, which serves as a marker to…”
BackgroundMolecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558 · see citing works
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491 · see citing works
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310 · cited 1× · see citing works
“Furthermore, the reduced expression of GHS-R1α was verified in induced pluripotent stem cells with a mutated or disrupted PARK2 gene, which is a mitochondrial gene implicated in mitochondrial quality control, mitophagy, and the development of early-onset PD (Pickrell and Youle, 2015), and in the SNpc of an in vivo mod…”
BackgroundSt-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · see citing works
Davson, H. (1977) · Nature · doi:10.1038/266661a0 · Cited by 2,229 · see citing works
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Howard, A., Feighner, S., Cully, D., Arena, J. P., Liberator, P., Rosenblum, C., Hamelin, M., Hreniuk, D. L., Palyha, O., Anderson, J., et al. (1996) · Science · doi:10.1126/science.273.5277.974 · Cited by 2,106 · cited 1× · see citing works
“Importantly, DAG is incapable of interacting with GHSR1α, yet the existence of distinct DAG-binding receptors has been postulated (Howard et al., 1996; Yanagi et al., 2018).”
BackgroundCirculating Ghrelin Levels Are Decreased in Human Obesity
Tschöp, M. H., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, É., & Heiman, M. L. (2001) · Diabetes · doi:10.2337/diabetes.50.4.707 · Cited by 1,992 · cited 1× · see citing works
“Similarly, obese individuals and patients with metabolic syndrome displayed reduced plasma ghrelin pools (Tschop et al., 2001; Rigamonti et al., 2002; Shiiya et al., 2002; Tesauro et al., 2005).”
BackgroundDate, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M. S., Suganuma, T., Matsukura, S., Kangawa, K., & Nakazato, M. (2000) · Endocrinology · doi:10.1210/en.141.11.4255 · Cited by 1,943 · cited 1× · see citing works
“Ghrelin is predominantly produced by gastric X/A-like cells that are located in the oxyntic gland of the stomach (Date et al., 2000), although a lower degree of the hormone is also expressed in various peripheral tissues, in lymphocytes and in the CNS (Ferrini et al.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924 · cited 1× · see citing works
“, 2004) or DNA repair factor Ku70, which was shown to scavenge proapoptotic Bax from mitochondria to support cellular survival (Cohen et al., 2004).”
BackgroundTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · cited 1× · see citing works
“Moreover, the rate of inhibitory serine phosphorylation of IRS1 (as a marker of insulin resistance), independent of even T2DM or the APOEε4 allele, rose gradually from previously healthy suspects to mild cognitive impairment (MCI) to AD patients, correlated with the quantity of Aß deposits and was inversely associated…”
Background(2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.114 · Cited by 1,832
Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0332-9 · Cited by 1,740 · cited 2× · see citing works
“As expected, mitophagy is widely impaired in respective models as well as in the brains of AD and PD patients, while the selective pharmacological enhancement of mitophagy can reverse several other pathological aspects, such as the generation of insoluble Aβ, Tau hyperphosphorylation, neuroinflammation, neuronal atrop…”
BackgroundSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 1× · see citing works
“Such and related investigations led to the designation of AD as “type 3 diabetes” (Steen et al., 2005; Moloney et al., 2010).”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1× · see citing works
“Therefore, in general, AG induces intraneuronal Ca2+ accumulation in an IP3-mediated manner, leading to the activation of the AMPKphosphorylating calmodulin-dependent protein kinase kinase-β (CaMKKß) (Hawley et al., 2005; Anderson et al., 2008).”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · cited 1× · see citing works
“This results in the intraneuronal accumulation of non-degraded and amyloid-containing autophagosomes, co-localizing strongly with neurons that display intracellular Tau pathology and the relative loss of mitochondria and other organelles (Cataldo et al., 1994; Nixon et al., 2005).”
BackgroundThe tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.
Gnanapavan, S., Kola, B., Bustin, S., Morris, D., McGee, P. J., Fairclough, P., Bhattacharya, S., Carpenter, R., Grossman, A., & Korbonits, M. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.6.8739 · Cited by 1,507 · cited 1× · see citing works
“GHS-R1α is widely transcribed in multiple key areas of the brain, such as the hippocampus, hypothalamus, cortex, ventral tegmental area (VTA), SN, spinal cord, dorsal and median raphe nuclei, sympathetic preganglionic nerves and endothelial cells of the cerebral vasculature, yet it is also expressed by various immune…”
BackgroundNLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487 · cited 3× · see citing works
“Over time, prolonged neuroinflammation encourages various other secondary complications, such as impairments in protein degradation, amyloid misfolding, Tau hyperphosphorylation (in conjunction with the inflammationperpetuating activation of the inflammasome), permeabilization of the BBB, peripheral immune cell infilt…”
BackgroundDouble perovskites as a family of highly active catalysts for oxygen evolution in alkaline solution
Grimaud, A., May, K. J., Carlton, C., Lee, Y.-L., Risch, M., Hong, W., Zhou, J.-G., & Yang, S.-H. (2013) · Nature Communications · doi:10.1038/ncomms3439 · Cited by 1,418 · see citing works
Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.
Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M. S., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K., & Matsukura, S. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.1.8129 · Cited by 1,390 · see citing works
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243 · see citing works
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1× · see citing works
“Shut-down of the growthfacilitating mTORC1 pathway, however, promotes the activity of the unc-51 like autophagy activating kinase (ULK1/2) initiation complex, which launches autophagosome maturation and the cellular purging of waste products, such as Aß, Tau or αsynuclein (Huang and Manning, 2008; Ma and Blenis, 2009;…”
BackgroundImpaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224 · see citing works
Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · cited 1× · see citing works
“Nonetheless, AD patients showed a massive decline in the transcriptional levels of the autophagy initiator Beclin1 during early stages of AD and strategies that have aimed to enhance the degree of autophagy, such as the lentivirusmediated expression of Beclin 1 or the autophagy-inducing blockage of mTor by rapamycin,…”
BackgroundGuan, X.-M., Yu, H., Palyha, O., McKee, K., Feighner, S., Sirinathsinghji, D., Smith, R. G., van der Ploeg, L., & Howard, A. (1997) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(97)00071-5 · Cited by 1,185 · cited 2× · see citing works
“GHS-R1α is widely transcribed in multiple key areas of the brain, such as the hippocampus, hypothalamus, cortex, ventral tegmental area (VTA), SN, spinal cord, dorsal and median raphe nuclei, sympathetic preganglionic nerves and endothelial cells of the cerebral vasculature, yet it is also expressed by various immune…”
BackgroundBrochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · cited 6× · see citing works
“Regarding immune infiltration, CD4+ T-cell-deleted mice were shown to be protected from MPTP-triggered neurodegeneration, proposing that the adaptive immune system is heavily involved in PD pathology (Brochard et al., 2009).”
BackgroundInfluentialBoland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119 · cited 1× · see citing works
“In contrast, the inhibition of lysosome-associated proteolytic enzymes was capable of producing an AD-like phenotype (Boland et al., 2008).”
BackgroundS-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury
Cho, D.-H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., & Lipton, S. A. (2009) · Science · doi:10.1126/science.1171091 · Cited by 1,092 · see citing works
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016) · Science · doi:10.1126/science.aab4138 · Cited by 1,085 · cited 9× · see citing works
“This is in line with the Mfn2-upregulating and Drp1-impeding function of PGC-1α (Peng et al., 2017), suggesting that AG stimulates the AMPK/PGC-1α axis to ameliorate mitochondrial fragmentation in response to cellular stress (Sirago et al., 2017).”
BackgroundInfluentialBezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., Clercq, E. D. D., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,081 · cited 17× · see citing works
“Moreover, AG downregulated the transcription of IL-1 and/or the inflammasome-activating cytokine TNF-α in face of MPTPinjury (PD), threohydroxyaspartate (THA)/kainic acid-assault (excitotoxicity), subarachnoid hemorrhage and SCI (Moon et al., 2009a; Ersahin et al., 2010; Lee J. et al., 2010; Lee et al., 2012, 2014b; A…”
BackgroundInfluentialMüller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034 · see citing works
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033 · see citing works
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · see citing works
Abizaid, A., Liu, Z.-W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., Roth, R. H., Sleeman, M. W., Picciotto, M. R., Tschöp, M. H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29867 · Cited by 984 · cited 3× · see citing works
“Acylated Ghrelin Induces Dopamine Transmission in the Ventral Tegmental Area and Stimulates Locomotor Activity and Memory Noteworthy, GHS-R1α was found to be expressed by ∼60% of dopaminergic neurons in the VTA of rats (Abizaid et al., 2006).”
BackgroundInflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966 · cited 2× · see citing works
“, 2019), chronic systemic inflammation, pathological immune cell infiltration into the brain (Amor and Woodroofe, 2014; Anderson et al., 2014; Stephenson et al., 2018), inflammasome activation (Ising et al.”
BackgroundGhrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue.
Hosoda, H., Kojima, M., Matsuo, H., & Kangawa, K. (2000) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.2000.4039 · Cited by 959 · cited 14× · see citing works
“Depending on the presence or absence of the acyl group at Ser3, mature ghrelin can be further distinguished into its active form, acylated ghrelin (AG), and desacylated ghrelin (DAG) (Hosoda et al., 2000; Yanagi et al., 2018).”
BackgroundInfluentialPARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953 · see citing works
Role of neuroinflammation in neurodegenerative diseases (Review)
Chen, W., Zhang, X., & Huang, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 933 · see citing works
Review: Activation patterns of microglia and their identification in the human brain
Boche, D., Perry, V. H., & Nicoll, J. A. R. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 911 · cited 13× · see citing works
“Moreover, the administration of LPS into older animals, which display lessened expression of GHS-R1α in the DVC, evoked the excessive release of TNF-α and IL-6, far greater than in younger littermates (Wu et al., 2009b).”
BackgroundInfluentialDixit, V., Schaffer, E., Pyle, R., Collins, G., Sakthivel, S. K., Palaniappan, R., Lillard, J. W., & Taub, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21134 · Cited by 904 · cited 18× · see citing works
“Furthermore, in vitro studies have shown that the administration of AG downregulated the synthesis of IL-1β, IL-6, and TNFα in human peripheral blood mononuclear cells following irritation with the mitogen phytohemagglutinin (Dixit et al., 2004).”
BackgroundInfluentialTwo defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity
El-Haschimi, K., Pierroz, D. D., Hileman, S. M., Bjørbæk, C., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9842 · Cited by 887 · cited 1× · see citing works
“Additionally, a high-fat diet, in an inflammation-mediated manner, promotes hypothalamic leptin resistance as well (El-Haschimi et al., 2000; Zhang et al., 2008).”
BackgroundLee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · see citing works
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870 · see citing works
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866 · cited 1× · see citing works
“In addition, heightened numbers of partially α-synuclein-reactive Th17 cells were discovered in the blood of PD patients (Sulzer et al., 2017); to the degree that PD has been postulated as an α-synuclein-reactive autoimmune disease (Benner et al., 2008; Hu, 2011).”
BackgroundKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works
Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835 · see citing works
Ghrelin controls hippocampal spine synapse density and memory performance
Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., da Silva, I., Horvath, B., Gaskin, F. S., Nonaka, N., Jaeger, L. B., Banks, W. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1656 · Cited by 828 · cited 29× · see citing works
“Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impai…”
BackgroundInfluentialSIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825 · cited 14× · see citing works
“Furthermore, AMPK phosphorylates glyceraldehyde 3- phosphate dehydrogenase (GAPDH) at Ser122 during starvation to encourage the nuclear trafficking of GAPDH and the displacement of SIRT1 from its repressor Deleted in Breast Cancer 1 (DBC1) (Chang et al., 2015).”
BackgroundInfluentialPathogenic Lysosomal Depletion in Parkinson's Disease
Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825 · cited 1× · see citing works
“This indicates that, similar to AD, autophagosomal efficiency is lost during PD, leading to the amassment of defective, waste-cluttered lysosomes and the failure of amyloid clearance (Chu et al., 2009; Alvarez-Erviti et al., 2010; Dehay et al., 2010).”
BackgroundNucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1*
Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., & Horio, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609554200 · Cited by 784 · cited 1× · see citing works
“Moreover, SIRT1 is capable of shuttling between the cytoplasm and nucleus (Tanno et al., 2007) and deacetylates nuclear PGC1α to initiate mitochondrial biogenesis (Lagouge et al.”
BackgroundLimiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 772 · cited 1× · see citing works
“, 2019), with NF-κB driving the synthesis of the inflammasome sensor NLRP3 as well as the pro-inflammatory cytokines pro-IL1/IL-1, pro-IL-18, TNF-α and many more (Afonina et al., 2017).”
BackgroundMoloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764 · cited 1× · see citing works
“Such and related investigations led to the designation of AD as “type 3 diabetes” (Steen et al., 2005; Moloney et al., 2010).”
BackgroundStranahan, A., Norman, E., Lee, K., Cutler, R., Telljohann, R., Egan, J., & Mattson, M. P. (2008) · Hippocampus · doi:10.1002/hipo.20470 · Cited by 755 · cited 1× · see citing works
“For instance, a highfat diet, which induces systemic insulin resistance, was shown to attenuate neuroprotective brain-derived neurotrophic factor levels, long-term potentiation (LTP) and dendritic spine density in the hippocampus of previously healthy mice, while accelerating Aβ plaque formation and memory loss in Aβt…”
BackgroundCPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Schlaepfer, I. R., & Joshi, M. (2020) · Endocrinology · doi:10.1210/endocr/bqz046 · Cited by 742 · see citing works
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733 · see citing works
UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
Andrews, Z. B., Liu, Z.-W., Walllingford, N., Erion, D. M., Borok, E., Friedman, J. M., Tschöp, M. H., Shanabrough, M., Cline, G., Shulman, G. I., et al. (2008) · Nature · doi:10.1038/nature07181 · Cited by 710 · see citing works
Clinical trials of new drugs for Alzheimer disease
Huang, L.-K., Chao, S.-P., & Hu, C.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0609-7 · Cited by 702 · cited 1× · see citing works
“Therefore, monotherapies are presumably an ineffective way of approaching AD and PD and are more likely to fail, supporting the concept that multi-targeted therapies are more profitable (Iqbal and Grundke-Iqbal, 2010; Adams, 2020; Huang et al., 2020).”
BackgroundCalorie restriction induces mitochondrial biogenesis and bioenergetic efficiency
López-Lluch, G., Hunt, N., Jones, B., Zhu, M., Jamieson, H., Hilmer, S., Cascajo, M. V., Allard, J., Ingram, D. K., Navas, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510452103 · Cited by 699 · cited 16× · see citing works
“As such, the function of variousmitochondrial master modulators, including AMPK and PGC1α, is disturbed in AD and PD.”
BackgroundInfluentialLoh, Y. (2008) · doi:10.3410/f.1123102.580425 · Cited by 698 · cited 1×
“Additionally, a high-fat diet, in an inflammation-mediated manner, promotes hypothalamic leptin resistance as well (El-Haschimi et al., 2000; Zhang et al., 2008).”
Banks, W. A., Tschöp, M., Robinson, S. M., & Heiman, M. L. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034827 · Cited by 691 · cited 27× · see citing works
“Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impai…”
BackgroundInfluentialHo, L., Qin, W., Pompl, P., Xiang, Z.-M., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 646 · cited 1× · see citing works
“For instance, a highfat diet, which induces systemic insulin resistance, was shown to attenuate neuroprotective brain-derived neurotrophic factor levels, long-term potentiation (LTP) and dendritic spine density in the hippocampus of previously healthy mice, while accelerating Aβ plaque formation and memory loss in Aβt…”
BackgroundThe promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Klatzmann, D., & Abbas, A. (2015) · Nature reviews. Immunology · doi:10.1038/nri3823 · Cited by 632 · cited 5× · see citing works
“For instance, the administration of AG succeeded in the animal model of colitis, showing downregulated local and systemic release of pro-inflammatory modulators, reduced inflammatory Th 1 activity, elevated action of immunosuppressive regulatory T-cells (Tregs), diminished oxidative stress, ameliorated intestinal tiss…”
BackgroundInfluentialHemodynamic and hormonal effects of human ghrelin in healthy volunteers.
Nagaya, N., Kojima, M., Uematsu, M., Yamagishi, M., Hosoda, H., Oya, H., Hayashi, Y., & Kangawa, K. (2001) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1483 · Cited by 629 · see citing works
SIRT1 and aging related signaling pathways.
Chen, C., Zhou, M., Ge, Y., & Wang, X.-B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111215 · Cited by 628 · see citing works
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer’s Disease
Mosconi, L., Pupi, A., & de Leon, M. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 605 · cited 2× · see citing works
“…(Muddapu et al., 2020), as evident in the brains of both AD (Lyingtunell et al., 1981; Hoyer et al., 1988; Ogawa et al., 1996; Drzezga et al., 2003; Mosconi et al., 2008) and PD patients (Huang et al., 2008; Hosokai et al., 2009; Liepelt et al., 2009; Borghammer et al., 2010; Berti et al., 2012).”
BackgroundMitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 598 · cited 2× · see citing works
“The mitochondrial pathology in AD and PD is further exacerbated by impaired mitochondrial biogenesis, a mechanism that leads to the generation of additional mitochondria to meet greater energetic demands in cells, and mitophagy, which is a form of autophagy that mediates the degradation of malfunctional, ROS-overprodu…”
BackgroundSpencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595 · see citing works
Lactate-supported synaptic function in the rat hippocampal slice preparation.
Schurr, A., West, C. A., & Rigor, B. (1988) · Science · doi:10.1126/science.3375817 · Cited by 594 · see citing works
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · see citing works
Nakamura, K., Nemani, V., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L. A., Zhang, J., Gardner, B. M., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 590 · cited 1× · see citing works
“While mutant α-synuclein enhances mitochondrial fragmentation, impairs the mitochondrial respiratory activity and induces neuronal death by inducing the displacement of wt α-synuclein from the inner-mitochondrial membrane (Kamp et al., 2010; Nakamura et al., 2011; Guardia-Laguarta et al., 2014), it must be noted that…”
BackgroundAmyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587 · cited 29× · see citing works
“The NTS, on the other hand, further projects across the entirety of the CNS, ultimately leading to the intestinal return of immune-suppressing signals through the afferent ends of the vagal nerve.”
BackgroundInfluentialDrzezga, A., Lautenschlager, N., Siebner, H., Riemenschneider, M., Willoch, F., Minoshima, S., Schwaiger, M., & Kurz, A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1194-1 · Cited by 587 · cited 2× · see citing works
“In accord with insulin resistance, glucose hypometabolism in the CNS, for instance within the cortex, has been linked to the transition from MCI to AD and cognitive dysfunction (Lyingtunell et al., 1981; Hoyer et al., 1988; Ogawa et al., 1996; Drzezga et al., 2003; Mosconi et al., 2008).”
BackgroundBonaz, B., Sinniger, V., & Pellissier, S. (2016) · The Journal of Physiology · doi:10.1113/jp271539 · Cited by 561 · see citing works
Frescas, D., Valenti, L. N., & Accili, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412357200 · Cited by 554 · cited 16× · see citing works
“As such, the function of variousmitochondrial master modulators, including AMPK and PGC1α, is disturbed in AD and PD.”
BackgroundInfluentialThe Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547 · cited 1× · see citing works
“The latter may be another consequence of insulin resistance, since insulin promotes the cerebral blood flow by enhancing NOdriven vasoconstriction and endothelin 1-mediated capillary recruitment (Craft, 2009).”
BackgroundAn update on inflamm-aging: mechanisms, prevention, and treatment
Xia, S., Zhang, X., Zheng, S., Khanabdali, R., Kalionis, B., Wu, J., Wan, W., & Tai, X. (2016) · Journal of Immunology Research · doi:10.1155/2016/8426874 · Cited by 538 · see citing works
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*
Hong, M., & Lee, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 533 · cited 1× · see citing works
“, 2011), hence the loss of insulin signaling initiates Tau hyperphosphorylation and aggregation in AD (Hong and Lee, 1997; Schubert et al., 2003, 2004).”
BackgroundSirt1 Protects the Heart from Ischemia/Reperfusion
Hsu, C.-P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., Shao, D., Takagi, H., Oka, S., & Sadoshima, J. (2010) · Circulation · doi:10.1161/circulationaha.110.958033 · Cited by 529 · cited 1× · see citing works
“, 2010) and, under conditions of cellular stress, FoxO1 drives the transcription of various anti-oxidant enzymes, such as the PGC1α-co-activated, mitochondrialMnSOD (St.-Pierre et al., 2006; Hsu et al., 2010; Tong et al., 2012).”
BackgroundLi, W.-G., Gavrila, D., Liu, X.-B., Wang, L.-X., Gunnlaugsson, S. T., Stoll, L. L., McCormick, M., Sigmund, C., Tang, C., & Weintraub, N. (2004) · Circulation · doi:10.1161/01.cir.0000127956.43874.f2 · Cited by 528 · cited 3× · see citing works
“Since DAG failed to modify inflammatory reactions by HUVECs, it was implied that the described inflammation-dampening effects were reliant on GHS-R1α (Li et al., 2004).”
BackgroundChaperone-mediated autophagy markers in Parkinson disease brains.
Álvarez-Erviti, L., Rodríguez-Oroz, M., Cooper, J., Caballero, C., Ferrer, I., Obeso, J., & Schapira, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 525 · cited 1× · see citing works
“This indicates that, similar to AD, autophagosomal efficiency is lost during PD, leading to the amassment of defective, waste-cluttered lysosomes and the failure of amyloid clearance (Chu et al., 2009; Alvarez-Erviti et al., 2010; Dehay et al., 2010).”
BackgroundMcKenzie, B., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 515 · cited 1× · see citing works
“Evidence that Acylated Ghrelin Opposes the Activation of the Inflammasome in the Brain The stimulation of the inflammasome and the associated pyroptosis, the “fiery death” of microglia, oligodendrocytes and other cells, a relatively recent upbringing, have been identified as major drivers of neuroinflammation, demyeli…”
BackgroundInhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1
Kamp, F., Exner, N., Lutz, A., Wender, N., Hegermann, J., Brunner, B., Nuscher, B., Bartels, T., Giese, A., Beyer, K., et al. (2010) · EMBO Journal · doi:10.1038/emboj.2010.223 · Cited by 505 · cited 1× · see citing works
“While mutant α-synuclein enhances mitochondrial fragmentation, impairs the mitochondrial respiratory activity and induces neuronal death by inducing the displacement of wt α-synuclein from the inner-mitochondrial membrane (Kamp et al., 2010; Nakamura et al., 2011; Guardia-Laguarta et al., 2014), it must be noted that…”
BackgroundBlázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 502 · cited 1× · see citing works
“Given the pivotal and neuroprotective role of insulin-signaling in the brain and that T2DM is one of the greatest known risk factors for AD and PD, it is no surprise that its early desensitization in the CNS, believed to predominantly occur in response to chronic inflammation, promotes the development of AD and PD (se…”
BackgroundA Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501 · cited 11× · see citing works
“This receptor has been reported to act as an inflammatory conductor for Aß, leading to the production of ROS and proinflammatory cytokines upon the interaction of fibrillar Aß with microglial or macrophage CD36 (Coraci et al., 2002; Bamberger et al., 2003; El Khoury et al., 2003; Demers et al., 2004).”
BackgroundInfluentialHypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.
López, M., Lage, R., Saha, A., Perez-Tilve, D., Vazquez, M. J., Varela, L., Sangiao-Alvarellos, S., Tovar, S., Raghay, K., Rodriguez-Cuenca, S., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.006 · Cited by 500 · cited 1× · see citing works
“In the other hand, AG does not modulate FAS in other brain areas, including the amygdala, striatum, hippocampus, several cortical regions and others (Lopez et al., 2008; Yanagi et al., 2018).”
BackgroundMorales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490 · cited 1× · see citing works
“Furthermore, pathogen-associated molecular patterns (PAMPs) that originate from cerebral infections, such as LPS, or, in the case of AD, infections with members of the Herpesviridae family and Hepatitis C virus, may further potentiate neuroinflammation (Morales et al., 2014; Sochocka et al., 2017; Cortes et al., 2018;…”
BackgroundNuclear control of respiratory gene expression in mammalian cells
Scarpulla, R. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20743 · Cited by 489 · cited 1× · see citing works
“…in mitochondria-associated genes protect from MPTP oxidative assault in cell and animal models of PD, whereas the deletion of PGC1α exacerbates MPTP-induced injury and excitotoxicity (Scarpulla, 2002, 2006; Kang and Hamasaki, 2005; St.-Pierre et al., 2006; Mudo et al., 2012; Quan et al., 2020).”
Backgroundα-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Guardia-Laguarta, C., Area-Gómez, E., Rüb, C., Liu, Y.-H., Magrané, J., Becker, D., Voos, W., Schon, E., & Przedborski, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2507-13.2014 · Cited by 489 · cited 2× · see citing works
“While mutant α-synuclein enhances mitochondrial fragmentation, impairs the mitochondrial respiratory activity and induces neuronal death by inducing the displacement of wt α-synuclein from the inner-mitochondrial membrane (Kamp et al., 2010; Nakamura et al., 2011; Guardia-Laguarta et al., 2014), it must be noted that…”
BackgroundInsulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488 · see citing works
Nagaya, N., Moriya, J., Yasumura, Y., Uematsu, M., Ono, F., Shimizu, W., Ueno, K., Kitakaze, M., Miyatake, K., & Kangawa, K. (2004) · Circulation · doi:10.1161/01.cir.0000149746.62908.bb · Cited by 488 · see citing works
Rheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483 · see citing works
CD36 Mediates the Innate Host Response to β-Amyloid
El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021546 · Cited by 483 · see citing works
MPTP Mouse Models of Parkinson’s Disease: An Update
Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11023 · Cited by 471 · see citing works
Ghrelin action in the brain controls adipocyte metabolism
Theander-Carrillo, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25811 · Cited by 465 · cited 1× · see citing works
“In the periphery, for example, independent of the hormone’s orexigenic effects, AG stimulated the expression of lipogenic enzymes (fatty acid synthase (FAS), lipoprotein lipase and more) and lessened the transcription of carnitine palmitoyltransferase Ia (CPT1a), a ratelimiting effector necessary to induce fatty acid…”
BackgroundStancu, I.-C., Cremers, N., Vanrusselt, H., Couturier, J., Vanoosthuyse, A., Kessels, S., Lodder, C., Brône, B., Huaux, F., Octave, J.-N., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-01957-y · Cited by 447 · see citing works
Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View
Cenini, G., Lloret, A., & Cascella, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2105607 · Cited by 435 · see citing works
Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433 · cited 1× · see citing works
“As a word of caution, while the β-oxidation of lipids has been proven in astrocytes, its utility by neurons is yet to be verified (Tracey et al., 2018).”
BackgroundJerlhag, E., Egecioglu, E., Dickson, S. L., Douhan, A., Svensson, L., & Engel, J. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00041.x · Cited by 431 · see citing works
Chu, Y., Dodiya, H. B., Aebischer, P., Olanow, C., & Kordower, J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 425 · see citing works
Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation*
Lutz, A., Exner, N., Fett, M. E., Schlehe, J. S., Kloos, K., Lämmermann, K., Brunner, B., Kurz-Drexler, A., Vogel, F., Reichert, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035774 · Cited by 421 · cited 2× · see citing works
“and OPA1 ameliorated excessive mitochondrial fission and impaired ATP production in PINK1/Parkin-mutant cells (Lutz et al., 2009) and shielded against MPTP-driven mitochondrial fragmentation, the stimulation of the pro-apoptotic activity of p53, Bax and PUMA, dopaminergic neuron and nerve terminal loss as well as moto…”
BackgroundThe Infectious Etiology of Alzheimer’s Disease
Sochocka, M., Zwolińska, K., & Leszek, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170313122937 · Cited by 399 · see citing works
Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398 · cited 12× · see citing works
“This receptor has been reported to act as an inflammatory conductor for Aß, leading to the production of ROS and proinflammatory cytokines upon the interaction of fibrillar Aß with microglial or macrophage CD36 (Coraci et al., 2002; Bamberger et al., 2003; El Khoury et al., 2003; Demers et al., 2004).”
BackgroundInfluentialUCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
Andrews, Z., Liu, Z.-W., Walllingford, N., Erion, D., Borók, E., Friedman, J., Tschöp, M., Shanabrough, M., Cline, G., Shulman, G., et al. (2009) · Nature · doi:10.1038/nature08132 · Cited by 392 · see citing works
Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E., Mosley, R., & Gendelman, H. E. (2010) · Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 391 · cited 2× · see citing works
“Moreover, it has been strongly implied that CD4 T helper (Th)1 and Th17 cells, for instance immunoreactive against α-synuclein, are the main lymphocyte populations that contribute to the death of dopaminergic neurons (Brochard et al., 2009; Reynolds et al., 2010).”
BackgroundResultKohno, D., Gao, H.-Z., Muroya, S., Kikuyama, S., & Yada, T. (2003) · Diabetes · doi:10.2337/diabetes.52.4.948 · Cited by 390 · see citing works
Hypothalamic CaMKK2 Contributes to the Regulation of Energy Balance
Anderson, K. A., Ribar, T. J., Lin, F., Noeldner, P. K., Green, M. F., Muehlbauer, M. J., Witters, L. A., Kemp, B. E., & Means, A. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.02.011 · Cited by 385 · see citing works
Morrow, V. A., Foufelle, F., Connell, J., Petrie, J., Gould, G., & Salt, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212831200 · Cited by 384 · cited 1× · see citing works
“, 2013) and the stimulation of AMPK was proven to trigger the AMPKconveyed activating phosphorylation of eNOS at Ser1177 in cultured human and rat endothelial cells, thus strengthening vasodilation in vivo (Morrow et al., 2003; Suzuki et al., 2008), it is highly likely that the AG-evoked liberation of NO is”
BackgroundMatrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Lakhan, S., Kirchgessner, A., Tepper, D. E., & Leonard, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00032 · Cited by 379 · cited 1× · see citing works
“, 2014a), the MMP family member that directly proteolyzes BBB components (Lakhan et al., 2013).”
BackgroundScarpulla, R. (2002) · Gene · doi:10.1016/s0378-1119(01)00809-5 · Cited by 371 · cited 1× · see citing works
“…in mitochondria-associated genes protect from MPTP oxidative assault in cell and animal models of PD, whereas the deletion of PGC1α exacerbates MPTP-induced injury and excitotoxicity (Scarpulla, 2002, 2006; Kang and Hamasaki, 2005; St.-Pierre et al., 2006; Mudo et al., 2012; Quan et al., 2020).”
BackgroundGhrelin increases anxiety-like behavior and memory retention in rats.
Carlini, V., Monzón, M., Varas, M., Cragnolini, A., Schiöth, H., Scimonelli, T., & Debarioglio, S. R. (2002) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/s0006-291x(02)02740-7 · Cited by 369 · see citing works
Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice.
Sun, Y.-X., Asnicar, M., Saha, P., Chan, L., & Smith, R. G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.004 · Cited by 368 · cited 1× · see citing works
“Furthermore, GHS-R1α antagonists, GOAT inhibitors and the genetic deletion of GHS-R1α enhanced the release of insulin, glucose tolerance, insulin sensitivity and weight loss in in vivo models of obesity (Sun et al., 2006; Esler et al., 2007; Longo et al., 2008; Barnett et al., 2010; Qi et al., 2011).”
BackgroundNitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Писарев, В. М., Tsiperson, V., Nemachek, C., Ciborowski, P. S., Przedborski, S., Mosley, R. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001376 · Cited by 359 · cited 1× · see citing works
“, 2017); to the degree that PD has been postulated as an α-synuclein-reactive autoimmune disease (Benner et al., 2008; Hu, 2011).”
BackgroundP1‐273: Changes in sleep/wake parameters in male PD‐APP transgenic mice
Shanks, E., Wafford, K., Hewes, N., McCarthy, A. P., Kinsley, P. J., & Edgar, D. M. (2012) · doi:10.1016/j.jalz.2012.05.553 · Cited by 358 · cited 2×
“Such findings indicate that autophagy-enhancing approaches must ensue early, since the mere upregulation of autophagy is insufficient at an advanced stage of AD, when insoluble and proteolysis-resistant aggregates have already formed in the brain (Majumder et al., 2011).”
BackgroundGonzález, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352 · cited 1× · see citing works
“Over time, prolonged neuroinflammation encourages various other secondary complications, such as impairments in protein degradation, amyloid misfolding, Tau hyperphosphorylation (in conjunction with the inflammationperpetuating activation of the inflammasome), permeabilization of the BBB, peripheral immune cell infilt…”
BackgroundSankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351 · see citing works
Carlini, V., Varas, M., Cragnolini, A., Schiöth, H., Scimonelli, T., & Debarioglio, S. R. (2004) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2003.11.150 · Cited by 347 · see citing works
Soriano, F. X., Liesa, M., Bach, D., Chan, D. C., Palacín, M., & Zorzano, A. (2006) · Diabetes · doi:10.2337/db05-0509 · Cited by 343 · see citing works
Tong, J., Prigeon, R., Davis, H., Bidlingmaier, M., Kahn, S., Cummings, D., Tschöp, M., & D'Alessio, D. (2010) · Diabetes · doi:10.2337/db10-0504 · Cited by 340 · see citing works
Role for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Kustermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 339 · see citing works
Liu, Y. J., McIntyre, R. L., Janssens, G. E., & Houtkooper, R. H. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111212 · Cited by 334 · cited 1× · see citing works
“A Possible Implication of Acylated Ghrelin in the Enhancement of Mitochondrial Fusion and Fission Unsurprisingly, in accordance with general mitochondrial dysfunction, the efficiency of mitochondrial fusion and fission gradually declines during the aging process and is disturbed in neurodegenerative diseases (Liu et a…”
BackgroundInsulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · cited 1× · see citing works
“Additionally, the co-emergence of insulin resistance, leading to reductions in PI3K/Akt/mTORC1-driven protein translation in dopaminergic neurons (Athauda and Foltynie, 2016; Anandhan et al., 2017; Holscher, 2019), presumably aggravates dopaminergic dysfunction and neuronal insensitivity toward AG.”
BackgroundCD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Hutter-Saunders, J. A. L., Estes, K. A., Kosloski, L. M., Allen, H. E., Dempsey, K., Torres‐Russotto, D. R., Meza, J. L., Santamaria, P. M., Bertoni, J. M., Murman, D. L., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9402-z · Cited by 325 · see citing works
Ghrelin directly targets the ventral tegmental area to increase food motivation.
Skibicka, K., Hansson, C., Álvarez-Crespo, M., Friberg, P., & Dickson, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.016 · Cited by 323 · see citing works
Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites.
Vriese, C. D., Grégoire, F., Lema-Kisoka, R., Waelbroeck, M., Robberecht, P., & Delporte, C. (2004) · Endocrinology · doi:10.1210/en.2004-0569 · Cited by 322 · cited 2× · see citing works
“…deacetylation halflife times (t1/2) of 4 h or 6.4 h, respectively, have been reported for AG in human plasma and∼27min in rat serum, whereas the degradation t1/2 of total circulatory ghrelin has been estimated to be as short as ∼9-11min (De Vriese et al., 2004; Liu et al., 2008; Tong et al., 2013).”
BackgroundInfluentialBrowne, T. C., McQuillan, K., McManus, R. M., O’Reilly, J.-A., Mills, K. H. G., & Lynch, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200947 · Cited by 322 · see citing works
Diet-Induced Obesity Causes Ghrelin Resistance in Arcuate NPY/AgRP Neurons
Briggs, D. I., Enriori, P. J., Lemus, M. B., Cowley, M. A., & Andrews, Z. B. (2010) · Endocrinology · doi:10.1210/en.2010-0556 · Cited by 320 · see citing works
Mudó, G., Mäkelä, J., Liberto, V. D., Tselykh, T. V., Olivieri, M., Piepponen, P., Eriksson, O., Mälkiä, A., Bonomo, A., Kairisalo, M., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0850-z · Cited by 315 · cited 1× · see citing works
“Jointly, the PGC1α-induced transcriptional changes in mitochondria-associated genes protect from MPTP oxidative assault in cell and animal models of PD, whereas the deletion of PGC1α exacerbates MPTP-induced injury and excitotoxicity (Scarpulla, 2002, 2006; Kang and Hamasaki, 2005; St.-Pierre et al., 2006; Mudo et al.…”
BackgroundJohnstone, M., Gearing, A. J. H., & Miller, K. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 313 · cited 17× · see citing works
“Moreover, AG downregulated the transcription of IL-1 and/or the inflammasome-activating cytokine TNF-α in face of MPTPinjury (PD), threohydroxyaspartate (THA)/kainic acid-assault (excitotoxicity), subarachnoid hemorrhage and SCI (Moon et al., 2009a; Ersahin et al., 2010; Lee J. et al., 2010; Lee et al., 2012, 2014b; A…”
BackgroundInfluentialPlasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients.
Rigamonti, A., Pincelli, A. I., Corrà, B., Viarengo, R., Bonomo, S., Galimberti, D., Scacchi, M., Scarpini, E., Cavagnini, F., & Müller, E. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.175r001 · Cited by 306 · see citing works
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Zhang, Y., Huang, N.-Q., Yan, F., Jin, H., Zhou, S.-Y., Shi, J.-S., & Jin, F. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.015 · Cited by 301 · cited 1× · see citing works
“GSK3β is a Tau-phosphorylating kinase whose activity is aberrantly enhanced in response to the desensitization of insulin and the associated loss of Akt-signaling during diabetes mellitus and AD (Jolivalt et al., 2008; Zhang et al., 2018).”
BackgroundThe Homeostatic Force of Ghrelin.
Yanagi, S., Sato, T., Kangawa, K., & Nakazato, M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.008 · Cited by 293 · see citing works
Andrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289 · see citing works
Jolivalt, C. G., Lee, C. A., Beiswenger, K., Smith, J., Orlov, M., Torrance, M., & Masliah, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21787 · Cited by 281 · cited 1× · see citing works
“GSK3β is a Tau-phosphorylating kinase whose activity is aberrantly enhanced in response to the desensitization of insulin and the associated loss of Akt-signaling during diabetes mellitus and AD (Jolivalt et al., 2008; Zhang et al., 2018).”
BackgroundJiang, H., Betancourt, L., & Smith, R. G. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0084 · Cited by 279 · cited 1× · see citing works
“GHS-R1α is widely transcribed in multiple key areas of the brain, such as the hippocampus, hypothalamus, cortex, ventral tegmental area (VTA), SN, spinal cord, dorsal and median raphe nuclei, sympathetic preganglionic nerves and endothelial cells of the cerebral vasculature, yet it is also expressed by various immune…”
Background“Is dopamine involved in Alzheimer's disease?”
Martorana, A., & Koch, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00252 · Cited by 276 · cited 1× · see citing works
“…insulin (Gault and Holscher, 2018; Holscher, 2019), as well as alterations of the dopaminergic system, including the extensive atrophy of substantia nigra pars compacta (SNpc)-located dopaminergic neurons and dopamine depletion in the striatum in PD (Martorana and Koch, 2014; Poewe et al., 2017).”
BackgroundGauna, C., Meyler, F. M., Janssen, J. A. M. J. L., Delhanty, P., Abribat, T., van Koetsveld, P. V., Hofland, L., Broglio, F., Ghigo, E., & van der Lely, A. J. (2004) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2004-0363 · Cited by 273 · cited 2× · see citing works
“, 2018), or DAG, to prevent AGencouraged glucose intolerance and hypoinsulinemia (Gauna et al., 2004; Kiewiet et al., 2009), may be profitable.”
BackgroundKim, Y.-S., Kim, S. S., Cho, J., Choi, D.-H., Hwang, O., Shin, D., Hong, S.-C., Beal, M., & Joh, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-04.2005 · Cited by 272 · see citing works
Therapeutic action of ghrelin in a mouse model of colitis.
González-Rey, E., Chorny, A., & Delgado, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.041 · Cited by 266 · cited 1× · see citing works
“For instance, the administration of AG succeeded in the animal model of colitis, showing downregulated local and systemic release of pro-inflammatory modulators, reduced inflammatory Th 1 activity, elevated action of immunosuppressive regulatory T-cells (Tregs), diminished oxidative stress, ameliorated intestinal tiss…”
BackgroundGlucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor
Barnett, B., Hwang, Y., Taylor, M. S., Kirchner, H., Pfluger, P., Bernard, V., Lin, Y.-Y., Bowers, E. M., Mukherjee, C., Song, W.-J., et al. (2010) · Science · doi:10.1126/science.1196154 · Cited by 265 · cited 1× · see citing works
“…GHS-R1α antagonists, GOAT inhibitors and the genetic deletion of GHS-R1α enhanced the release of insulin, glucose tolerance, insulin sensitivity and weight loss in in vivo models of obesity (Sun et al., 2006; Esler et al., 2007; Longo et al., 2008; Barnett et al., 2010; Qi et al., 2011).”
BackgroundInsulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
Neth, B., & Craft, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00345 · Cited by 263 · cited 5× · see citing works
“On the other hand, it must be noted that the prevalence of cerebral insulin resistance during AD leads to defects in the metabolism of glucose, which is believed to provoke the use of β-oxidation and lipids (ketones) as primary energy sources for neurons (Neth and Craft, 2017).”
BackgroundInfluentialOrtega-Martinez, S. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00046 · Cited by 263 · cited 2× · see citing works
“In such AD in vivo models, AG rescued from hippocampal atrophy, synaptic damage and the degeneration of cholinergic projections, heightened brain glycogen levels, diminished Aß aggregation and deposition, blocked Aβimparted deficits in LTPs, normalized plasticity-associated p-CREB levels, improved insulin sensitivity,…”
BackgroundRegulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR
Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., & Fukamizu, A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.642 · Cited by 262 · cited 16× · see citing works
“As such, the function of variousmitochondrial master modulators, including AMPK and PGC1α, is disturbed in AD and PD.”
BackgroundInfluentialThe effects of ghrelin on inflammation and the immune system.
Baatar, D., Patel, K., & Taub, D. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.019 · Cited by 260 · cited 2× · see citing works
“As concluded elsewhere in the context of colitis, the inflammation-ameliorating mechanisms of AG include (i) the attenuation of systemic innate and adaptive immune responses, which is dependent on the direct suppression of leukocytes; (ii) the AG-stimulated liberation of tissue-strengthening GH and insulin-like growth…”
BackgroundMitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
Onyango, I. G., Dennis, J., & Khan, S. M. (2016) · Aging and Disease · doi:10.14336/ad.2015.1007 · Cited by 260 · cited 2× · see citing works
“The mitochondrial pathology in AD and PD is further exacerbated by impaired mitochondrial biogenesis, a mechanism that leads to the generation of additional mitochondria to meet greater energetic demands in cells, and mitophagy, which is a form of autophagy that mediates the degradation of malfunctional, ROS-overprodu…”
BackgroundBaek, S. H., Park, S. J., Jeong, J. I., Kim, S. H., Han, J., Kyung, J. W., Baik, S.-H., Choi, Y., Choi, B. Y., Park, J. S., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2385-16.2017 · Cited by 258 · see citing works
Chang, C.-M., Su, H., Zhang, D.-H., Wang, Y., Shen, Q.-H., Liu, B., Huang, R., Zhou, T.-H., Peng, C., Wong, C. C. L., et al. (2015) · Molecules and Cells · doi:10.1016/j.molcel.2015.10.037 · Cited by 258 · see citing works
Skibicka, K., Hansson, C., Egecioglu, E., & Dickson, S. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00294.x · Cited by 258 · see citing works
The Area Postrema: A Brain Monitor and Integrator of Systemic Autonomic State
Price, C. J., Hoyda, T. D., & Ferguson, A. V. (2008) · The Neuroscientist · doi:10.1177/1073858407311100 · Cited by 257 · cited 1× · see citing works
“In concert, the area postrema, the nucleus tractus solitarius and the dorsal motor nucleus of the vagus (DMV) form the dorsal vagal complex (DVC) that serves as a commanding platform for the autonomic nervous system, navigating gastrointestinal motility, secretory activity and pancreatic hormone release (Price et al.,…”
BackgroundNass, R., Pezzoli, S. S., Oliveri, M. C., Patrie, J. T., Harrell, F. E., Clasey, J. L., Heymsfield, S. B., Bach, M. A., Vance, M. L., & Thorner, M. O. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00003 · Cited by 255 · cited 2× · see citing works
“A clinical trial, although slightly underpowered, has indicated that the injection of the ghrelin analog MK-677 proved to sustain IGF1 release in the long-term, which led to enhancements in the lean body mass of healthy, aged and non-obese subjects after a 1-year treatment period (Nass et al., 2008).”
BackgroundWaseem, T., Duxbury, M., Ito, H., Ashley, S., & Robinson, M. (2008) · Surgery · doi:10.1016/j.surg.2007.09.039 · Cited by 249 · see citing works
Liu, J., Prudom, C. E., Nass, R., Pezzoli, S. S., Oliveri, M. C., Johnson, M. L., Veldhuis, P., Gordon, D. A., Howard, A. D., Witcher, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2235 · Cited by 248 · cited 1× · see citing works
“4 h, respectively, have been reported for AG in human plasma and∼27min in rat serum, whereas the degradation t1/2 of total circulatory ghrelin has been estimated to be as short as ∼9-11min (De Vriese et al., 2004; Liu et al., 2008; Tong et al., 2013).”
BackgroundGurney, K., Estrada, E. Y., & Rosenberg, G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.006 · Cited by 243 · cited 1× · see citing works
“Furthermore, the cerebral infusion of LPS, in a mostly MMP-3-conyeyed manner, injured the BBB through the upregulation of MMP-3, MMP9, and the MMPdriven degradation of various tight junction proteins in rodents (Gurney et al., 2006).”
BackgroundBarcia, C., Ros, C., Annese, V., Gómez, A., Ros-Bernal, F., Aguado-Yera, D., Martı́nez-Pagán, M., de Pablos, V., Fernández-Villalba, E., & Herrero, M. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.17 · Cited by 242 · cited 18× · see citing works
“Moreover, AG downregulated the transcription of IL-1 and/or the inflammasome-activating cytokine TNF-α in face of MPTPinjury (PD), threohydroxyaspartate (THA)/kainic acid-assault (excitotoxicity), subarachnoid hemorrhage and SCI (Moon et al., 2009a; Ersahin et al., 2010; Lee J. et al., 2010; Lee et al., 2012, 2014b; A…”
BackgroundInfluentialEsler, W., Rudolph, J., Claus, T., Tang, W.-F., Barucci, N., Brown, S.-E., Bullock, W., Daly, M., Decarr, L., Li, Y., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0239 · Cited by 232 · cited 1× · see citing works
“Furthermore, GHS-R1α antagonists, GOAT inhibitors and the genetic deletion of GHS-R1α enhanced the release of insulin, glucose tolerance, insulin sensitivity and weight loss in in vivo models of obesity (Sun et al., 2006; Esler et al., 2007; Longo et al., 2008; Barnett et al., 2010; Qi et al., 2011).”
BackgroundZhang, J., Ke, K.-F., Liu, Z., Qiu, Y.-H., & Peng, Y.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075786 · Cited by 231 · see citing works
Alzheimer Disease, a Multifactorial Disorder Seeking Multi-therapies
Iqbal, K., & Grundke-Iqbal, I. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.04.006 · Cited by 231 · cited 1× · see citing works
“Therefore, monotherapies are presumably an ineffective way of approaching AD and PD and are more likely to fail, supporting the concept that multi-targeted therapies are more profitable (Iqbal and Grundke-Iqbal, 2010; Adams, 2020; Huang et al., 2020).”
BackgroundMetabolic abnormalities associated with mild cognitive impairment in Parkinson disease
Huang, C.-R., Mattis, P., Perrine, K., Brown, N., Dhawan, V., & Eidelberg, D. (2008) · Neurology · doi:10.1212/01.wnl.0000304050.05332.9c · Cited by 230 · cited 2× · see citing works
“Interestingly, various studies have indicated that PD patients also exhibit cortical glucose hypometabolism and diminished blood flow in this area (Huang et al., 2008; Hosokai et al., 2009; Liepelt et al., 2009; Borghammer et al., 2010; Berti et al., 2012), a decreased rate of glucose consumption in the frontal lobe a…”
BackgroundMinguell, J., Erices, A., & Conget, P. (2001) · doi:10.1007/978-3-540-29678-2_3446 · Cited by 230 · cited 1×
“Further in vivo studies in the MPTP model support the idea that, in conjunction with BBB injury and the loss of tight junction proteins in the nigrostriatal area, the pathological infiltration of lymphocytes and other immune cells as well as the T-cell-driven induction of microglia occur in the SN (Kurkowska-Jastrzebs…”
ResultScreening of innate immune receptors in neurodegenerative diseases: A similar pattern
Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W., & Fassbender, K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.018 · Cited by 228 · cited 2× · see citing works
“, 2009), whereas the enhanced transcription of TLR2 and TLR4 have been detected in α-synuclein and MPTP mouse models of PD (Panaro et al., 2008; Letiembre et al., 2009), indicating that immune regulation is harmfully altered in AD and PD.”
BackgroundDifferential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin.
Pan, W., Tu, H., & Kastin, A. (2006) · Peptides · doi:10.1016/j.peptides.2005.12.014 · Cited by 226 · see citing works
Cataldo, A., Hamilton, D. J., & Nixon, R. (1994) · Brain Research · doi:10.1016/0006-8993(94)91858-9 · Cited by 225 · see citing works
Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
Liu, J., Liu, W., Li, R., & Yang, H. (2019) · Cells · doi:10.3390/cells8070712 · Cited by 224 · see citing works
Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?
Hoyer, S., Oesterreich, K., & Wagner, O. (1988) · Journal of Neurology · doi:10.1007/bf00314304 · Cited by 224 · cited 3× · see citing works
“In accord with insulin resistance, glucose hypometabolism in the CNS, for instance within the cortex, has been linked to the transition from MCI to AD and cognitive dysfunction (Lyingtunell et al., 1981; Hoyer et al., 1988; Ogawa et al., 1996; Drzezga et al., 2003; Mosconi et al., 2008).”
BackgroundNeurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?
Muddapu, V. R., Dharshini, S. P., Chakravarthy, V., & Gromiha, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00213 · Cited by 218 · cited 2× · see citing works
“In any way, the desensitization of insulin in the CNS is linked to reduced cerebral glucose uptake, the diminished liberation of lactate, another pivotal energy source for neurons, by astrocytes and chronic glucose hypometabolism (Muddapu et al., 2020), as evident in the brains of both AD (Lyingtunell et al.”
BackgroundDysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
Dunn, L., Allen, G., Mamais, A., Ling, H., Li, A., Duberley, K., Hargreaves, I., Pope, S., Holton, J., Lees, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.001 · Cited by 217 · cited 1× · see citing works
“, 2015) as well as the reduced expression of glycolytic enzymes in the putamen and the cerebellum (Dunn et al., 2014).”
BackgroundGhrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation.
Chung, H., Kim, E., Lee, D.-H., Seo, S., Ju, S., Lee, D., Kim, H., & Park, S. (2007) · Endocrinology · doi:10.1210/en.2006-0991 · Cited by 213 · cited 1× · see citing works
“, 2018) and primary hypothalamic neurons during oxygen and glucose withdrawal (Chung et al., 2007).”
BackgroundRecent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211 · see citing works
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
Pan, T., Kondo, S., Zhu, W., Xie, W., Jankovic, J. J., & Le, W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.003 · Cited by 210 · cited 2× · see citing works
“…overexpression of Beclin 1 or the utility of the autophagy-activator and mTor-inhibitor rapamycin rescued the apoptosis of dopaminergic neurons in response to the loss of proteasomal function or the accumulation of α-synuclein in cells and animals (Pan et al., 2008; Spencer et al., 2009).”
BackgroundRegulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex
Jaeger, P. A., Pickford, F., Sun, C.-H., Lucin, K. M., Masliah, E., & Wyss-Coray, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011102 · Cited by 209 · cited 1× · see citing works
“Nonetheless, AD patients showed a massive decline in the transcriptional levels of the autophagy initiator Beclin1 during early stages of AD and strategies that have aimed to enhance the degree of autophagy, such as the lentivirusmediated expression of Beclin 1 or the autophagy-inducing blockage of mTor by rapamycin,…”
BackgroundKanaan, N. M., Pigino, G. F., Brady, S. T., Lazarov, O., Binder, L. I., & Morfini, G. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.003 · Cited by 208 · cited 1× · see citing works
“, 2018), the degeneration of axons (Kandan et al., 2013), the development of type 2 diabetes mellitus (T2DM), the cerebral desensitization of growth and neurotrophic factors, in particular insulin (Gault and Holscher, 2018; Holscher, 2019), as well as alterations of the dopaminergic system, including the extensive atr…”
BackgroundGhrelin Down-regulates Proinflammatory Cytokines in Sepsis Through Activation of the Vagus Nerve
Wu, R.-Q., Dong, W., Cui, X.-X., Zhou, M., Simms, H., Ravikumar, T. S., & Wang, P. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251614.42290.ed · Cited by 203 · see citing works
Pedrós, I., Petrov, D., Allgaier, M., Sureda, F. X., Barroso, E., Beas‐Zárate, C., Auladell, C., Pallàs, M., Vázquez‐Carrera, M., Casadesús, G., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.025 · Cited by 203 · cited 2× · see citing works
“Additionally, the transcription of the biogenesis-mediators PGC1α and mitochondrial nuclear respiratory factor (NRF)1/2 were reduced in the hippocampi of the APPswe/PS1dE9 mice (Pedros et al., 2014).”
BackgroundMoon, M., Kim, H. G., Hwang, L., Seo, J.-H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9037-x · Cited by 203 · cited 13× · see citing works
“…as exemplified in the previous pages, but also protected endothelial cells of the BBB and neurons from apoptosis in various contexts, leading to the reduced release of the microglial inflammatory activator MMP-3 (Kim et al., 2005; Moon et al., 2009a; Lee J. et al., 2010; Lee et al., 2015).”
BackgroundInfluentialZilberter, Y., & Zilberter, M. Y. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24064 · Cited by 199 · cited 3× · see citing works
“These early impediments in the neuronal insulin and glucose metabolism have been proposed to trigger a detrimental bioenergetic shift from glucose to alternative and less efficient energy substrates (reviewed in Neth and Craft, 2017) and have been suggested to precede any other pathological alteration, including even…”
BackgroundAndrews, Z. B., Horvath, B., Barnstable, C. J., Elseworth, J., Yang, L., Beal, M. F., Roth, R. H., Matthews, R. T., & Horvath, T. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4269-04.2005 · Cited by 199 · see citing works
Dramatic Shifts in Circulating CD4 but not CD8 T Cell Subsets in Mild Alzheimer's Disease
Larbi, A., Pawelec, G., Witkowski, J., Schipper, H., Derhovanessian, E., Goldeck, D., & Fulop, T. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1015 · Cited by 198 · cited 2× · see citing works
“…responses, such as a total reduction in naive T-cells, a tendency of T-cells to differentiate into CD4+ subsets or the elevated activity of pro-inflammatory CD4+ Th17 cells (Shalit et al., 1995; Richartz-Salzburger et al., 2007; Speciale et al., 2007; Larbi et al., 2009; Saresella et al., 2011).”
BackgroundResultFerrini, F., Salio, C., Lossi, L., & Merighi, A. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602779 · Cited by 197 · cited 30× · see citing works
“The NTS, on the other hand, further projects across the entirety of the CNS, ultimately leading to the intestinal return of immune-suppressing signals through the afferent ends of the vagal nerve.”
BackgroundInfluentialAMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Peixoto, C. A., Oliveira, W. H. D., Araújo, S. M. D. R., & Nunes, A. K. S. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.013 · Cited by 196 · cited 13× · see citing works
“AG is also involved in the regulation of the adaptive immune system, which is based on the modulation of T-cells.”
BackgroundInfluentialThe Hypothalamic Mechanisms of the Hypophysiotropic Action of Ghrelin
Wren, A., Small, C., Fribbens, C., Neary, N., Ward, H., Seal, L., Ghatei, M., & Bloom, S. (2002) · Neuroendocrinology · doi:10.1159/000066629 · Cited by 196 · see citing works
Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways
Zhang, J., Ng, S., Wang, J., Zhou, J., Tan, S.-H., Yang, N., Lin, Q., Xia, D., & Shen, H. (2015) · Autophagy · doi:10.1080/15548627.2015.1023981 · Cited by 195 · see citing works
Cerebral blood flow in Alzheimer’s disease
Roher, A., Debbins, J., Malek-Ahmadi, M., Chen, K.-W., Pipe, J., Maze, S., Belden, C. M., Maarouf, C., Thiyyagura, P., Mo, H., et al. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s34874 · Cited by 194 · see citing works
Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging
Quan, Y., Xin, Y.-G., Tian, G., Zhou, J.-T., & Liu, X.-J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9423593 · Cited by 188 · cited 2× · see citing works
“…in mitochondria-associated genes protect from MPTP oxidative assault in cell and animal models of PD, whereas the deletion of PGC1α exacerbates MPTP-induced injury and excitotoxicity (Scarpulla, 2002, 2006; Kang and Hamasaki, 2005; St.-Pierre et al., 2006; Mudo et al., 2012; Quan et al., 2020).”
Background
Flagged first, then by citations
12 of the 476 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- Berti V. C. Polito P. Borghammer S. Ramat L. Mosconi E. Vanzi M. T.. (2012). Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. Q. J. Nuclear Med. Mol. Imag. 56, 299– 308. Available online at: https://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2012N03A0299 22695340 PMC3846292
- Fang W. Y. Qu X. K. Yuan F. Wang W. G. Fei J.. (2013). AMPK activity is down-regulated in endothelial cells of GHS-R−/− mice. Int. J. Clin. Exp. Pathol. 6, 1770– 1780. Available online at: http://europepmc.org/article/PMC/3759483 24040441 PMC3759483
- Jerlhag E. Egecioglu E. Dickson S. L. Engel J. A. (2010). Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 211, 415– 422. 10.1007/s00213-010-1907-7 20559820 PMC2908453 · DOI
- Konturek P. C. Brzozowski T. Engel M. Burnat G. Gaca P. Kwiecien S.. (2009). Ghrelin ameliorates colonic inflammation. role of nitric oxide and sensory nerves. J. Physiol. Pharmacol. 60, 41– 47. 19617644
- Kutty B. M. Subramanian S. (2014). Amyloid beta lowering and cognition enhancing effects of ghrelin receptor analog [D-Lys (3)] GHRP-6 in rat model of obesity. Biochem. Biophys. 51, 257– 262. Available online at: https://www.semanticscholar.org/paper/Amyloid-beta-lowering-and-cognition-enhancing-of-in-Madhavadas-Kutty/709c2106abfeee0d1d6c8477b8ded7e630ad0997?p2df 25296496
- Majumder S. Richardson A. Strong R. Oddo S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS ONE 6: e25416. 10.1371/journal.pone.0025416 21980451 PMC3182203 · DOI
- Mao Y. Q. Cheng J. Yu F. J. Li H. Q. Guo C. Y. Fan X. N. (2015). Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kappa B inhibition. Cell. Physiol. Biochem. 37, 563– 576. 10.1159/000430377 26329041 · DOI
- Poewe W. Seppi K. Tanner C. M. Halliday G. M. Brundin P. Volkmann J. (2017). Parkinson disease. Nat. Rev. Dis. Primers 3: 17013 10.1038/nrdp.2017.13 28332488 · DOI · Paper page
- Yokochi M. (2007). Mesolimbic and mesocortical pathways in parkinson disease. Brain Nerve 59, 943– 951. 10.11477/mf.1416100129 17886476 · DOI
- Zhang X. Zhang G. Zhang H. Karin M. Bai H. Cai D. (2008). Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61– 73. 10.1016/j.cell.2008.07.043 18854155 PMC2586330 · DOI · Paper page
Cited by
Sorted by citations
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248 · see citing works
Self-citationAcetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan
Bradshaw, P. (2021) · Antioxidants · doi:10.3390/antiox10040572 · Cited by 162 · see citing works
“Ghrelin has shown efficacy for the treatment of several mouse models of neurodegenerative disease consistent with the neuroprotective effects of AMPK signaling [208,209].”
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101 · see citing works
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63 · see citing works
“Moreover, ghrelin can enhance several energy metabolic pathways like beta oxidation [133] and alleviate neuronal inflammation by reducing proinflammatory cytokines [134].”
BackgroundRusso, C., Valle, M. S., Russo, A., & Malaguarnera, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113432 · Cited by 40 · see citing works
Hang, Z.-C., Lei, T., Zeng, Z.-H., Cai, S.-L., Bi, W.-Y., & Du, H. (2021) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2021.112343 · Cited by 39 · see citing works
Reich, N., & Hölscher, C. (2024) · Frontiers in neuroendocrinology (Print) · doi:10.1016/j.yfrne.2024.101122 · Cited by 35 · see citing works
“Other pathologic events include, for example, oxidative stress, mitochondrial damage, dysfunctional autophagy, loss of hippocampal neurogenesis and BBB and microvascular injury (Reich & Holscher, 2020).”
InfluentialSelf-citationApplication of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
Hu, D., Jin, Y., Hou, X.-Q., Zhu, Y., Chen, D., Tai, J.-J., Chen, Q.-Q., Shi, C., Ye, J., Wu, M., et al. (2023) · Marine Drugs · doi:10.3390/md21010043 · Cited by 30 · see citing works
“Most clinical drug trials target at Aβ and tau, but the clinical failures of the recent decades indicate that there are further pathological mechanisms [146].”
BackgroundGhrelin as a Biomarker of “Immunometabolic Depression” and Its Connection with Dysbiosis
Gajewska, A., Strzelecki, D., & Gawlik-Kotelnicka, O. (2023) · Nutrients · doi:10.3390/nu15183960 · Cited by 27 · see citing works
“(AD) [80], and Huntington’s disease (HD) [81], all of which have been associated with ghrelin.”
BackgroundRecent insights into autophagy and metals/nanoparticles exposure
Li, Q., Feng, Y., Wang, R., Liu, R., Ba, Y., & Huang, H. (2023) · Toxicological Research · doi:10.1007/s43188-023-00184-2 · Cited by 25 · see citing works
“At present, accumulating studies have identified autophagy as being widely involved in diverse physiological and pathogenetic processes underlying neurodegenerative diseases [13], cancers [14], and metabolic diseases [15].”
BackgroundAdvances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
Giorgioni, G., Bello, F. D., Quaglia, W., Botticelli, L., Cifani, C., Bonaventura, E. M. D., Bonaventura, M. D. D., & Piergentili, A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02191 · Cited by 23 · see citing works
Park, M., Park, K. H., Choi, B. J., Han, W.-H., Yoon, H. J., Jung, H. Y., Lee, J. W., Song, I., Lim, D., Choi, M., et al. (2022) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2115082119 · Cited by 23 · see citing works
Li, N., Xiao, K., Mi, X., Li, N., Guo, L., Wang, X., Sun, Y.-X., Li, G.-D., & Zhou, Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108871 · Cited by 20 · see citing works
Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 18 · see citing works
Beyond Appetite: Acylated Ghrelin As A Learning, Memory and Fear Behavior-modulating Hormone.
Reich, N., & Hölscher, C. (2022) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104952 · Cited by 18 · see citing works
Self-citation“Sibling” battle or harmony: Crosstalk between nesfatin-1 and ghrelin
Chen, X., Dong, J., Jiao, Q., Du, X., Bi, M., & Jiang, H. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04193-6 · Cited by 17 · see citing works
Harris, B., Roberts, B. R., DiMarco, G. M., Maldonado, K. A., Okwunwanne, Z., Savonenko, A., & Soto, P. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114126 · Cited by 14 · see citing works
THE ROLE OF CIRCADIAN REGULATION OF GHRELIN LEVELS IN PARKINSON’S DISEASE (LITERATURE REVIEW)
Tarianyk, K., Lytvynenko, N. V., Shkodina, A., & Kaidashev, I. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202107132 · Cited by 14 · see citing works
Ghrelin system in Alzheimer's disease
Tian, J., Wang, T., & Du, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102655 · Cited by 17 · see citing works
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease
Pradhan, L. K., Sahoo, P. K., Chauhan, S., & Das, S. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02009-7 · Cited by 9 · see citing works
“AG also encourages hippocampal neurogenesis and revives cognition in AD (Reich and Hölscher 2020).”
BackgroundHan, S., Utami, R., Qin, Y., Liam-or, R., Sreedharan, J., Davies, J. S., & Al-Jamal, K. T. (2025) · Small · doi:10.1002/smll.202504517 · Cited by 8 · see citing works
Changes in Circulating Acylated Ghrelin and Neutrophil Elastase in Diabetic Retinopathy
Trotta, M., Gesualdo, C., Russo, M., Lepre, C. C., Petrillo, F., Vastarella, M., Nicoletti, M., Simonelli, F., Hermenean, A., D’Amico, M., et al. (2024) · Medicina · doi:10.3390/medicina60010118 · Cited by 8 · see citing works
“Therefore, in line with the novel clinical applications suggested for AG in Alzheimer’s and Parkinson’s disease [65], lipodystrophy [66], reproductive toxicity in cancer patients [67] and heart failure [68], serum AG could be considered a sensitive peripheral marker of distinction between NPDR and…”
BackgroundEmerging Relevance of Ghrelin in Programmed Cell Death and Its Application in Diseases
Zhang, X., Zeng, Z.-H., Liu, Y., & Liu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417254 · Cited by 8 · see citing works
“Additionally, acylated ghrelin can stimulate the activation of SIRT1 to boost autophagy, which can eliminate harmful proteins [95].”
BackgroundLi, N., Li, N., Yang, L., Gu, H.-T., Ji, J., Zhou, H.-L., Zhu, Q., Yu, M., Sun, Y.-X., & Zhou, Y. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac230 · Cited by 8 · see citing works
Zhang, M., Yang, L., Jia, J., Xu, F., Gao, S.-S., Han, F.-B., Deng, M., Wang, J., Li, V., Yu, M., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06914-y · Cited by 6 · see citing works
The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
Almohmadi, N., Al-kuraishy, H., Hussein, K., Turkistani, A., Yousef, F. M., Al-Gareeb, A., Abdelaziz, A. M., Elewa, Y. H., & Batiha, G. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11014-w · Cited by 5 · see citing works
“Both ghrelin and SCFAs have neuroprotective effects against PD neuropathology [ 70, 71].”
Futran-Sheinberg, E. J., Urbina, V., Nava, S., Sanchez, D., Guzmán-Valdivia, G., & Zetter, M. A. (2025) · Neuroglia · doi:10.3390/neuroglia6030035 · Cited by 4 · see citing works
“In recent years, the acylated form of ghrelin has shown protective effects in Alzheimer’s and other neurodegenerative diseases [130], remarkably indicating that the post-translational modification of neuropeptides could be a milestone for their protective effects.”
Jászberényi, M., Thurzó, B., Jayakumar, A., & Schally, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313086 · Cited by 4 · see citing works
“This way, while treatment with ghrelin, acylated ghrelin, or synthetic agonists [181,253,256,272] appears advantageous in the long run, the inhibition of BChE [271,273] may provide both long-term and short-term beneficial effects in Alzheimer’s disease.”
The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Justich, M., Rojas, O. L., & Fasano, A. (2023) · Seminars in neurology · doi:10.1055/s-0043-1771468 · Cited by 4 · see citing works
Kamarehei, M., & Zahednasab, H. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102534 · Cited by 3 · see citing works
GHS-R1a deficiency protects against lipopolysaccharide-induced spatial memory impairment in mice.
Liu, J.-R., Li, N., Wei, C., Han, F.-B., Deng, M., Ma, J., Zou, X.-Y., Zhou, Y., Yang, R., & Yuan, H. (2024) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2024.150270 · Cited by 3 · see citing works
Kumar, D., Kondaveeti, S., Agrawal, M., Kumar, A., Awasthi, A., Mahmood, S., Singh, T. G., & Kumar, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05857-1 · Cited by 2 · see citing works
Kadiri, W. E., Perrignon-Sommet, M., Delpont, B., Graber, M., Mohr, S., Mouillot, T., Devilliers, H., Grall, S., Liénard, F., Georges, M., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230270 · Cited by 2 · see citing works
Jeskanen, H., Heikkinen, S., Kervinen, I., Lehtisalo, J., Ngandu, T., Willman, R.-M., Rosa, J., Hoffmann, D., FinnGen, Leinonen, V., et al. (2026) · Alzheimer's Research & Therapy · doi:10.1186/s13195-026-01957-1 · Cited by 1 · see citing works
Sun, Q., & Chen, C. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111956 · Cited by 1
Tian, J., Du, E., Jia, K., Wang, T.-J., Guo, L., Zigman, J., & Du, H. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-231002 · Cited by 1 · see citing works
“[74, 75].”
Multi-faceted small molecule for Alzheimer’s disease
Park, M., Jin, H., & Bae, J.-S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369110 · Cited by 1
“In the contrast, the activation of the ghrelin receptor in immune cells has a positive effect on the suppression of systemic immune responses (Jeon et al., 2019; Reich et al., 2020).”
Zhou, L.-X., Cheng, Y., Zhao, W.-Y., Sun, X.-L., Hu, F., Ge, M., Zhang, Y., Zhang, G.-C., Dong, B.-R., & Liu, X.-L. (2026) · Aging Cell · doi:10.1111/acel.70732
“Our results showed that ghrelin treatment attenuated the expression of microglial senescence markers and increased Beclin1 and LC3-II levels, indicating improved autophagy-related molecular changes, consistent with its well-known protective effects (Chung et al. 2018; Reich and Holscher 2020).”
Druk, I. V., Usacheva, E., Zamahina, O. V., & Kulikova, O. (2026) · Scientific Bulletin of the Omsk State Medical University · doi:10.61634/2782-3024-2025-19-2-10
Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation
Sopko, Z., Pačesová, A., Železná, B., & Maletínská, L. (2026) · Bioscience Reports · doi:10.1042/bsr20250362
“By activating NPY/AgRP neurons in the hypothalamus, it drives feeding behavior and fat storage [73].”
The protective PLCG2 variants delay Alzheimer's disease onset age in APOE ϵ4 carriersPreprint
Jeskanen, H., Heikkinen, S., Kervinen, I., Lehtisalo, J., Ngandu, T., Willman, R.-M., Rosa, J., Hoffmann, D., FinnGen, Leinonen, V., et al. (2025) · medRxiv · doi:10.1101/2025.09.22.25336304
The Dual Actions of Melatonin and Ghrelin Hormones in Autism Spectrum Disorder
Ayob, S. M., Mustafa, N., & Nanakali, Q. (2026) · passer of basic and applied sciences · doi:10.24271/psr.2025.548550.2368
“This indicates its potential as a target for treating neurodegenerative disorders, including Parkinson’s and Alzheimer’s diseases [15] .”
- Authors
- Reich, N., & Hölscher, C.
- Affiliations
- Lancaster University (GB)
- Henan University of Chinese Medicine (CN)
- Corresponding author
- Reich, Niklas
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-12-14
- Volume
- 14
- Pages
- 614828-614828
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC7767977
- OpenAlex
- W3111850577
- Cited by
- 48
- References
- 476
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 6
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- acylated ghrelin, Alzheimer's disease, Parkinson's disease, neuroprotection, oxidative stress, mitochondrial dysfunction, autophagy, mitophagy, systemic inflammation, blood-brain barrier, dopamine depletion, neurogenesis, multi-target therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review